lets not forget some loyal shareholders threatened litigation against a RRS director.for review, an interesting and journalistically comical google findhttp://english.horseedmedia.net/articles/27911.shtml
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%